
Despite cervical cancer being nearly 100% preventable through routine screening, almost one in three U.S. women are behind, and the numbers have been moving in the wrong direction for a decade. Kara Egan, CEO and Co-Founder of Teal Health, left a career as a health tech investor to fix one of the most overlooked gaps in women's preventive care. In May 2025, Teal received the only FDA authorization for at-home cervical cancer screening, and just seven months later had scaled to all 50 states. In this conversation, Kara breaks down what it actually takes to redesign a screening process that hasn't meaningfully changed in 80 years, how regulatory alignment and updated clinical guidelines are reshaping the landscape, and what at-home diagnostics signal for the future of preventive care and women's health access broadly. Kara Egan, CEO and Co-Founder, Teal Health Megan Antonelli, CEO, HealthIMPACT Live
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Five Good Things with Janae Sharp and Megan Antonelli

Nursing at the Center: How AI, Virtual Care, and Human-Centered Design Are Transforming the Bedside at Advocate Health

From FDA-Cleared Wearables to AI Caregivers: Rune Labs CEO on Closing the Gap in Parkinson's Care

FQHCs Are Infrastructure: What HR1 Means for Health System Leaders
Free AI-powered recaps of Digital Health Talks - Changemakers Focused on Fixing Healthcare and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.